Barclays raises Cytokinetics stock price target on strong Myqorzo sales
Barclays raises Cytokinetics stock price target on strong Myqorzo sales Investing.com
Covered in this story
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.